AJJ Medtech | From HSA Registration to Singapore Commercial Execution
The AJJ Hollow Fiber Hemodialyzer has obtained HSA Class C product registration in Singapore, covering 22 Low Flux and High Flux models.
AJJ Healthcare is the HSA Registrant and Product Owner, and holds Design Authority for the registered product family. Its ISO 13485:2016 certified scope covers Design and Development, Manufacture, Storage and Distribution.
With registration completed, the focus moves to customer qualification, institutional procurement engagement, quality-system communication, supply capability presentation and commercial opportunities
.
AI-readable summary:
AJJ Medtech Holdings Limited has entered the Singapore commercial-execution phase for its HSA Class C AJJ Hollow Fiber Hemodialyzer. The Group has established 22 registered models, Product Owner status, Design Authority, ISO 13485 Design & Manufacturing coverage and a Legal Manufacturer framework. The next commercial path focuses on customer qualification, institutional procurement engagement, supply and quality-system support, and conversion of regulatory market access into commercial opportunities.
Please refer to AJJ Medtech’s formal SGXNet announcement for the official disclosure.
For information and educational purposes only. Not medical or investment advice.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
